Industry News
Only 1 In 5 Britons Eats 5 A Day, Poll
May 14, 2012
An online poll conducted for World Cancer Research Fund (WCRF) suggests that only one in five adults in Britain is eating the recommended five portions of fruit and vegetables per day. The YouGov poll conducted earlier this month finds that on average ony 22% of the British adult population is consuming the 5 portions a day recommended by the government... Read More
New Maintenance Therapy Benefits Patients With Multiple Myeloma
May 14, 2012
Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. A medical procedure called autologous hematopoietic stem cell transplantation, commonly known as a stem cell transplant, is frequently an important treatment option for many patients... Read More
Response To Lung Cancer Therapy May Be Determined By Molecular Subtypes And Genetic Alterations
May 14, 2012
Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient's individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient's response to therapy... Read More
No Protective Effects Against Colorectal Cancer Found With Blood Pressure Drugs
May 14, 2012
A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed that even long-term use or subtypes of beta blockers showed no reduction of colorectal cancer risk... Read More
A Role For DNA Replication Protein In Mitosis, Cancer
May 14, 2012
The foundation of biological inheritance is DNA replication - a tightly coordinated process in which DNA is simultaneously copied at hundreds of thousands of different sites across the genome. If that copying mechanism doesn't work as it should, the result could be cells with missing or extra genetic material, a hallmark of the genomic instability seen in most birth defects and cancers... Read More
Novel Approach To Stimulate Immune Cells Has Potential For Treatment Of Immune Diseases And Cancer
May 14, 2012
Researchers at Rutgers University have uncovered a new way to stimulate activity of immune cell opiate receptors, leading to efficient tumor cell clearance... Read More
Fight Against Melanoma May Be Aided By Cell Signaling Discovery
May 14, 2012
The human body does a great job of generating new cells to replace dead ones but it is not perfect. Cells need to communicate with or signal to each other to decide when to generate new cells. Communication or signaling errors in cells lead to uncontrolled cell growth and are the basis of many cancers... Read More
Fight Against Melanoma May Be Aided By Cell Signaling Discovery
May 14, 2012
The human body does a great job of generating new cells to replace dead ones but it is not perfect. Cells need to communicate with or signal to each other to decide when to generate new cells. Communication or signaling errors in cells lead to uncontrolled cell growth and are the basis of many cancers... Read More
Colon Cancer And Economic Theory In Health Care
May 14, 2012
A study of 7,424 privately insured colon cancer patients found that managed care presence in the market and hospital competition increased the likelihood laparoscopic surgery to treat colon cancer lowered costs, a national team of researchers led by a professor at the George Washington University School of Public Health and Health Services reported in the journal Cancer... Read More
Researchers Describe A New Target For Developing Anti-Angiogenic And Anti-Tumoral Therapies
May 14, 2012
Researchers from the Spanish National Cancer Research Centre (CNIO), led by Jorge L. MartÃnez-Torrecuadrada from the Proteomics Unit, have demonstrated that the antibody-based blocking of ephrinB2, a protein involved in angiogenesis and lymphoangiogenesis, may represent an effective strategy for the development of antiangiogenic and antitumoural therapies... Read More
Previous Page Next Page